Literature DB >> 16002710

Reduced three-dimensional motility in dehydrated airway mucus prevents neutrophil capture and killing bacteria on airway epithelial surfaces.

Hirotoshi Matsui1, Margrith W Verghese, Mehmet Kesimer, Ute E Schwab, Scott H Randell, John K Sheehan, Barbara R Grubb, Richard C Boucher.   

Abstract

Cystic fibrosis (CF) lung disease is characterized by persistent lung infection. Thickened (concentrated) mucus in the CF lung impairs airway mucus clearance, which initiates bacterial infection. However, airways have other mechanisms to prevent bacterial infection, including neutrophil-mediated killing. Therefore, we examined whether neutrophil motility and bacterial capture and killing functions are impaired in thickened mucus. Mucus of three concentrations, representative of the range of normal (1.5 and 2.5% dry weight) and CF-like thickened (6.5%) mucus, was obtained from well-differentiated human bronchial epithelial cultures and prepared for three-dimensional studies of neutrophil migration. Neutrophil chemotaxis in the direction of gravity was optimal in 1.5% mucus, whereas 2.5% mucus best supported neutrophil chemotaxis against gravity. Lateral chemokinetic movement was fastest on airway epithelial surfaces covered with 1.5% mucus. In contrast, neutrophils exhibited little motility in any direction in thickened (6.5%) mucus. In in vivo models of airway mucus plugs, neutrophil migration was inhibited by thickened mucus (CF model) but not by normal concentrations of mucus ("normal" model). Paralleling the decreased neutrophil motility in thickened mucus, bacterial capture and killing capacity were decreased in CF-like thickened mucus. Similar results with each mucus concentration were obtained with mucus from CF cultures, indicating that inhibition of neutrophil functions was mucus concentration dependent not CF source dependent. We conclude that concentrated ("thick") mucus inhibits neutrophil migration and killing and is a key component in the failure of defense against chronic airways infection in CF.

Entities:  

Mesh:

Year:  2005        PMID: 16002710     DOI: 10.4049/jimmunol.175.2.1090

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms.

Authors:  Hirotoshi Matsui; Victoria E Wagner; David B Hill; Ute E Schwab; Troy D Rogers; Brian Button; Russell M Taylor; Richard Superfine; Michael Rubinstein; Barbara H Iglewski; Richard C Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-20       Impact factor: 11.205

Review 2.  Update in cystic fibrosis 2005.

Authors:  Frank J Accurso
Journal:  Am J Respir Crit Care Med       Date:  2006-05-01       Impact factor: 21.405

3.  Role of CD95 in pulmonary inflammation and infection in cystic fibrosis.

Authors:  Katrin Anne Becker; Brian Henry; Regan Ziobro; Burkhard Tümmler; Erich Gulbins; Heike Grassmé
Journal:  J Mol Med (Berl)       Date:  2012-09       Impact factor: 4.599

4.  The lactoperoxidase system links anion transport to host defense in cystic fibrosis.

Authors:  Gregory E Conner; Corinne Wijkstrom-Frei; Scott H Randell; Vania E Fernandez; Matthias Salathe
Journal:  FEBS Lett       Date:  2006-12-19       Impact factor: 4.124

Review 5.  Effective mucus clearance is essential for respiratory health.

Authors:  Scott H Randell; Richard C Boucher
Journal:  Am J Respir Cell Mol Biol       Date:  2006-03-09       Impact factor: 6.914

6.  Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses.

Authors:  Samuel K Lai; Ying-Ying Wang; Kaoru Hida; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

7.  Motile invaded neutrophils in the small intestine of Toxoplasma gondii-infected mice reveal a potential mechanism for parasite spread.

Authors:  Janine L Coombes; Brittany A Charsar; Seong-Ji Han; Joanna Halkias; Shiao Wei Chan; Anita A Koshy; Boris Striepen; Ellen A Robey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

8.  The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

Authors:  Jung Soo Suk; Samuel K Lai; Ying-Ying Wang; Laura M Ensign; Pamela L Zeitlin; Michael P Boyle; Justin Hanes
Journal:  Biomaterials       Date:  2009-01-26       Impact factor: 12.479

9.  Cystic Fibrosis: The Mechanisms of Pathogenesis of an Inherited Lung Disorder.

Authors:  Mark T Clunes; Richard C Boucher
Journal:  Drug Discov Today Dis Mech       Date:  2007

10.  The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis.

Authors:  Katrin Anne Becker; Joachim Riethmüller; Yang Zhang; Erich Gulbins
Journal:  Open Respir Med J       Date:  2010-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.